Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS) Global Day Annually the International ALS/MND Associations celebrates 21 June as the global day of recognition of ALS/MND, a disease that affects people in every country of the world. ALS/MND is a global problem. It doesn’t discriminate on the basis of ethnicity or region, there are patients all over the world. For every […]
Hepatocellular carcinoma
Hepatocellular carcinoma (HCC) Liver cancer is a global health challenge, with an estimated incidence of >1 million patients by 2025. Primary liver cancer is one that started in the liver. There are 5 main types. The type of liver cancer depends on the cell type that the cancer started in. If cancer began somewhere else […]
WHO Backs Molnupiravir for High-Risk Covid-19 Patients
The ninth update of WHO’s guideline on COVID-19 therapeutics includes a conditional recommendation on molnupiravir, a new antiviral medicine. This is the first oral antiviral medicine which is included in the treatment guidelines for COVID-19, as this is a new medicine, there is little safety information; WHO recommends active monitoring for drug safety, along […]
Gastrointestinal stromal tumors (GISTs)
Tyrosine Kinase Inhibitors Used in Gastrointestinal stromal tumors (GISTs) Introduction A gastrointestinal stromal tumor is a rare cancer, which are often found during an endoscopy or CT scan for an unrelated reasons. Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal tract. GISTs start in very early types of special […]
Role of Direct Factor Xa inhibitors in Cardiovascular Events
Introduction Direct Factor Xa inhibitors are a type of anticoagulant drugs which act by binding selectively and reversibly to the clotting factor Xa. Factor Xa plays an important role in the blood clotting mechanism. When an injury occurred, they forming a mesh to prevent loss of blood. However, clots can form within the body and cause blockages in the veins, arteries, […]
Benefits of Direct Factor Xa inhibitors over Warfarin
Benefits of Direct Factor Xa inhibitors over Warfarin Introduction Compared to vitamin K antagonists (VKAs), these target-specific drugs have a fixed dosing with no need for international normalized ratio (INR) monitoring, a wider therapeutic index, rapid onset and short half-lives, and few drug and food interactions, so you may not need to take blood tests […]
Chronic Myeloid Leukemia (CML)
A quick overview over chronic myeloid leukemia (CML) Chronic myeloid leukemia (CML) is an uncommon form of the bone marrow cancer. In CML we can see an increased number of white blood cells (WBC) in the blood. Too many blood stem cells become a type of WBC which is called granulocytes. They aren’t healthy white blood cells and are […]
Chronic lymphocytic leukemia (CLL)
Quick review over chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia which is also called CLL is a cancer of the blood and bone marrow which usually is worsen slowly; many patients don’t have any symptoms for at least the first few years, but over time, the cancer grows and spreads to other parts of the body, including the liver, spleen, and lymph […]
Small Lymphocytic Lymphoma SLL
Small Lymphocytic Lymphoma (SLL) overview: Chronic lymphocytic leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) are cancers of the immune system; which affect lymphocytes. CLL and SLL are basically the same, the only difference is each cancer is primarily located in a different part of the body. When cancer occurs in bloodstream and the bone […]
Mantle cell lymphoma (MCL)
Quick overview of Mantle cell lymphoma (MCL) Mantle cell lymphoma (MCL) is grouped as one of the rare B-cell non-Hodgkin lymphoma (NHL). In non-Hodgkin lymphoma cancer, the lymphatic system is affected. About 6 to 8 percent of all NHLs are Mantle cell lymphoma (MCL). This type of cancer is called “mantle cell lymphoma”, because […]